Optimizing Proton Pump Inhibitors (PPI) Prescribing With EHR-Based Decision Support
Recruiting
N/A
Interventional Study
Prescribing Patterns, Physician
Physician's Practice Patterns
Drug Utilization Review
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 50 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Health Services Research
- Participants needed
- 372 (estimated)
- Sponsor
- University of California, Los Angeles · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The proposed study is a quality improvement initiative designed to rigorously evaluate new variations of UCLA Health's proton pump inhibitor (PPI) order panels, building on internal quality improvement efforts to optimize prescribing workflows within the Electronic Health Record (EHR). PPIs are notoriously overprescribed, and the study team has identified that the CareConnect default prescription …
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* UCLA Health primary care physicians who have a clinical full-time equivalency of at least 25%.
Exclusion Criteria:
* Physicians with a clinical full-time equivalency of less than 25%
Contacts